NO20001569D0 - Bisetere av 1-oksa, aza og tianaftalen-2-oner som fosfolambaninhibitorer - Google Patents
Bisetere av 1-oksa, aza og tianaftalen-2-oner som fosfolambaninhibitorerInfo
- Publication number
- NO20001569D0 NO20001569D0 NO20001569A NO20001569A NO20001569D0 NO 20001569 D0 NO20001569 D0 NO 20001569D0 NO 20001569 A NO20001569 A NO 20001569A NO 20001569 A NO20001569 A NO 20001569A NO 20001569 D0 NO20001569 D0 NO 20001569D0
- Authority
- NO
- Norway
- Prior art keywords
- bisethers
- thianaphthalene
- aza
- oxa
- ones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93711997A | 1997-09-24 | 1997-09-24 | |
| US99015097A | 1997-12-12 | 1997-12-12 | |
| US10411498A | 1998-06-25 | 1998-06-25 | |
| PCT/FI1998/000755 WO1999015523A1 (en) | 1997-09-24 | 1998-09-24 | Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20001569L NO20001569L (no) | 2000-03-24 |
| NO20001569D0 true NO20001569D0 (no) | 2000-03-24 |
Family
ID=27379660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20001569A NO20001569D0 (no) | 1997-09-24 | 2000-03-24 | Bisetere av 1-oksa, aza og tianaftalen-2-oner som fosfolambaninhibitorer |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1017691A1 (no) |
| JP (1) | JP2003525838A (no) |
| KR (1) | KR20010015607A (no) |
| CN (1) | CN1143857C (no) |
| AU (1) | AU735729B2 (no) |
| BR (1) | BR9813216A (no) |
| CA (1) | CA2304849A1 (no) |
| EA (1) | EA003084B1 (no) |
| EE (1) | EE04494B1 (no) |
| HU (1) | HUP0003647A3 (no) |
| ID (1) | ID24373A (no) |
| IL (1) | IL134662A0 (no) |
| NO (1) | NO20001569D0 (no) |
| NZ (1) | NZ503044A (no) |
| PL (1) | PL339493A1 (no) |
| SK (1) | SK3902000A3 (no) |
| TR (1) | TR200000764T2 (no) |
| WO (1) | WO1999015523A1 (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002008217A2 (en) | 2000-07-21 | 2002-01-31 | Chugai Seiyaku Kabushiki Kaisha | COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS |
| CA2442476A1 (en) * | 2001-03-30 | 2002-10-10 | Pfizer Products Inc. | Pyridazinone aldose reductase inhibitors |
| US7572910B2 (en) | 2003-02-20 | 2009-08-11 | Pfizer, Inc. | Pyridazinone aldose reductase inhibitors |
| FR2970964B1 (fr) * | 2011-01-28 | 2013-12-13 | Univ Claude Bernard Lyon | Nouveaux derives d'azacoumarines presentant une activite inhibitrice des pompes mdr |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2543945A1 (de) * | 1975-10-02 | 1977-04-21 | Troponwerke Gmbh & Co Kg | 2-benzopyranonderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| GB8529362D0 (en) * | 1985-11-28 | 1986-01-02 | Pfizer Ltd | Quinolone cardiac stimulants |
| GB8630702D0 (en) * | 1986-12-23 | 1987-02-04 | Wellcome Found | Quinoline compound |
| EP0355583B1 (en) * | 1988-08-10 | 1995-01-25 | Otsuka Pharmaceutical Co., Ltd. | Cardiotonics |
| CA2022236A1 (en) * | 1989-07-31 | 1991-02-01 | Hiroaki Yanagisawa | Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders |
| DE4337906A1 (de) * | 1993-11-08 | 1995-05-11 | Cassella Ag | Verwendung von Cumarinderivaten |
-
1998
- 1998-09-24 JP JP2000512828A patent/JP2003525838A/ja active Pending
- 1998-09-24 ID IDW20000564A patent/ID24373A/id unknown
- 1998-09-24 IL IL13466298A patent/IL134662A0/xx unknown
- 1998-09-24 HU HU0003647A patent/HUP0003647A3/hu unknown
- 1998-09-24 SK SK390-2000A patent/SK3902000A3/sk unknown
- 1998-09-24 TR TR2000/00764T patent/TR200000764T2/xx unknown
- 1998-09-24 EE EEP200000179A patent/EE04494B1/xx not_active IP Right Cessation
- 1998-09-24 NZ NZ503044A patent/NZ503044A/en unknown
- 1998-09-24 PL PL98339493A patent/PL339493A1/xx unknown
- 1998-09-24 AU AU93508/98A patent/AU735729B2/en not_active Ceased
- 1998-09-24 EP EP98946482A patent/EP1017691A1/en not_active Withdrawn
- 1998-09-24 CA CA002304849A patent/CA2304849A1/en not_active Abandoned
- 1998-09-24 CN CNB98809438XA patent/CN1143857C/zh not_active Expired - Fee Related
- 1998-09-24 EA EA200000352A patent/EA003084B1/ru not_active IP Right Cessation
- 1998-09-24 BR BR9813216-4A patent/BR9813216A/pt not_active IP Right Cessation
- 1998-09-24 KR KR1020007003094A patent/KR20010015607A/ko not_active Application Discontinuation
- 1998-09-24 WO PCT/FI1998/000755 patent/WO1999015523A1/en not_active Application Discontinuation
-
2000
- 2000-03-24 NO NO20001569A patent/NO20001569D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9813216A (pt) | 2000-08-29 |
| CA2304849A1 (en) | 1999-04-01 |
| SK3902000A3 (en) | 2000-12-11 |
| EA003084B1 (ru) | 2002-12-26 |
| HUP0003647A3 (en) | 2002-12-28 |
| EE200000179A (et) | 2001-04-16 |
| ID24373A (id) | 2000-07-13 |
| WO1999015523A1 (en) | 1999-04-01 |
| KR20010015607A (ko) | 2001-02-26 |
| NZ503044A (en) | 2001-08-31 |
| EA200000352A1 (ru) | 2000-10-30 |
| CN1271357A (zh) | 2000-10-25 |
| EP1017691A1 (en) | 2000-07-12 |
| TR200000764T2 (tr) | 2001-03-21 |
| PL339493A1 (en) | 2000-12-18 |
| IL134662A0 (en) | 2001-04-30 |
| JP2003525838A (ja) | 2003-09-02 |
| AU735729B2 (en) | 2001-07-12 |
| CN1143857C (zh) | 2004-03-31 |
| HUP0003647A2 (hu) | 2001-08-28 |
| AU9350898A (en) | 1999-04-12 |
| NO20001569L (no) | 2000-03-24 |
| EE04494B1 (et) | 2005-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20005928L (no) | Bicykliske pyrimidiner og bicykliske 3,4-dihydropyrimidiner som inhibitorer av cellulær proliferasjon | |
| HK1044545A1 (zh) | 貝他分泌酶組合物及其方法 | |
| NO20002162L (no) | Tienopyrimidin- og tienopyridinderivater nyttige som anticancer midler | |
| DK1105123T3 (da) | Farmaceutiske præparater indeholdende lipase-inhibitorer og chitosan | |
| NO20003096L (no) | Sammensetninger og fremgangsmÕter for behandling av ADD | |
| NO983187L (no) | Substituerte aza- og diazacykloheptan og -cyklooktan-forbindelse og deres anvendelse | |
| ZA200306490B (en) | Inhibitors of factor Xa. | |
| NO20004550D0 (no) | Enzyminhibitorer | |
| NO991922D0 (no) | Heteroarylsuccinamider og deres anvendelse som metalloproteinaseinhibitorer | |
| NO20011216D0 (no) | Azetidinderivater, fremstilling og medisiner inneholdende disse | |
| DK0944590T3 (da) | Aminoguanidiner og alkoxyguanidiner som proteaseinhibitorer | |
| AU7294098A (en) | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses | |
| PT956294E (pt) | Inibidores da trombina | |
| NO20002181D0 (no) | Steriliseringsinnpakning, anvendelse derav og fremgangsmÕte for sterilisering | |
| DK1023268T3 (da) | Isoquinoliner som urokinaseinhibitorer. | |
| NO995513L (no) | N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK- | |
| HK1020741A1 (en) | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase | |
| DK1214302T3 (da) | Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere | |
| DE60024101D1 (de) | Enzyminhibitoren | |
| NO20004904L (no) | C11 oksymyl og hydroksylaminoprostaglandiner anvendbare som medikamenter | |
| TR199501644A2 (tr) | Skualen sintetaz inhibitörleri. | |
| NO20001569L (no) | Bisetere av 1-oksa, aza og tianaftalen-2-oner som fosfolambaninhibitorer | |
| DE60020583D1 (de) | Synchronisierung von pcm und pseudozufallstaktgebern | |
| NO984647D0 (no) | Spesifikke immunofilinligander som antiastmatika og immunosuppressiva | |
| NO20001176D0 (no) | Anvendelse av blandinger av polymerer og aminoisothiasoler som biocider |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |